Related Experiment Video
Updated: Jul 17, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
[The heart in hypertension]
1Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland. hennersdorf@med.uni-duesseldorf.de
Insights
Hypertensive heart disease involves left ventricular hypertrophy and microangiopathy, leading to heart dysfunction and increased cardiovascular risk. Effective antihypertensive therapy can regress hypertrophy, reducing mortality risk.
Area of Science:
- Cardiology
- Hypertension Research
- Pathophysiology
Context:
- Hypertensive heart disease encompasses left ventricular hypertrophy, microangiopathy, and endothelial dysfunction.
- These conditions result in diastolic and systolic dysfunction, arrhythmias, and elevated cardiovascular risk.
- Pathophysiologically, it involves cardiac myocyte hypertrophy, interstitial fibrosis, and arteriole media hypertrophy.
Purpose:
- To detail the pathophysiological mechanisms and clinical manifestations of hypertensive heart disease.
- To highlight early diagnostic signs and the progression of cardiac changes due to hypertension.
- To emphasize the therapeutic importance of antihypertensive therapy for regression of cardiac hypertrophy and risk reduction.
Summary:
- Microangiopathy and diastolic dysfunction are identified as the earliest indicators of hypertensive heart disease.
- Persistent arterial hypertension leads to the development of left ventricular hypertrophy, often asymmetric, followed by systolic dysfunction.
- Clinical symptoms include angina pectoris, dyspnea, and rhythm disorders, with left ventricular hypertrophy increasing the risk of malignant ventricular arrhythmias.
Impact:
- Early diagnosis and intervention are crucial for managing hypertensive heart disease.
- Antihypertensive therapy is the cornerstone of treatment, aiming to reverse cardiac remodeling.
- Effective management can significantly decrease mortality risk associated with hypertensive heart disease.
Abstract:
The term hypertensive heart disease covers the entities of left ventricular hypertrophy, microangiopathy and endothelial dysfunction resulting in diastolic and systolic dysfunction, arrhythmias and increased cardiovascular risk. From the pathophysiological point of view, this is caused by the hypertrophy of cardiac myocytes, interstitial fibrosis and media hypertrophy of the arterioles. Microangiopathy can be diagnosed as the earliest sign of hypertensive heart disease, with diastolic dysfunction also being found as an early change. In further persisting arterial hypertension left ventricular hypertrophy develops (often asymmetric) and later a systolic dysfunction. Clinically, the patients suffer from angina pectoris, dyspnea and rhythm disorders. Left ventricular hypertrophy is associated with an increased risk of malignant ventricular arrhythmias. Thus, the main therapeutic principle should be antihypertensive therapy with the goal of regression of hypertrophy leading to decreased mortality risk.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension I: Introduction
Heart Failure II: Pathophysiology
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Hypertension III: Clinical Manifestations and Diagnostic Studies
